Inclusion Criteria:  Any gender Age > 18 Hospitalized adult male and female patients with Laboratory-confirmed novel coronavirus (SARS-CoV-2) infection Laboratory-confirmed novel coronavirus (SARS-CoV-2) infection All Confirmed COVID-19 Patients by PCR or highly suspected patients admitted to the chest department's isolation unit during the duration of the study Able to understand and provide voluntary informed consent. Informed consent for participation in the study (consent can be oral if written consent cannot be expressed Vaccination with any type of SARS-CoV-2 vaccine  Exclusion Criteria:  Other medical condition other than COVID-19 or laboratory abnormality that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study Suspected or known active systemic bacterial, viral (except SARS-CoV2 infection) or fungal infections Active herpes zoster infection Any physical examination findings and/or history of any illness that, in the opinion of the investigator, might confound the results of the study or pose an additional risk to the patient by their participation in the study Participation in other clinical trials of investigational treatments for COVID-19.